E
CG Oncology, Inc. CGON
$18.74 -$3.50-15.74%
Recommendation
Sell
Prev Close
$22.24
Volume
2,558,818
Avg Vol (90D)
728,198
Market Cap
$1.70B
Dividend & Yield
--
52-Week Range
$21.61 - $46.99
P/E (TTM)
--
EPS (TTM)
-$1.41
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Very Weak
Volatility Index
Weak
Dividend Index
--
Headlines
CG Oncology (NASDAQ:CGON) Reaches New 12-Month Low - What's Next?
4/3/2025 - MarketBeat
Brokers Offer Predictions for CG Oncology FY2029 Earnings
4/3/2025 - MarketBeat
Cantor Fitzgerald Lowers Earnings Estimates for CG Oncology
4/3/2025 - MarketBeat
CG Oncology Looks Attractive At Current Prices (Rating Upgrade)
4/2/2025 - Seeking Alpha - Long Ideas
CG Oncology Looks Attractive At Current Prices (Rating Upgrade)
4/2/2025 - SeekingAlpha
Pictet Asset Management Holding SA Buys New Stake in CG Oncology, Inc. (NASDAQ:CGON)
4/2/2025 - MarketBeat
CG Oncology (NASDAQ:CGON) Trading Down 8.1% - Should You Sell?
4/1/2025 - MarketBeat
CG Oncology's (CGON) "Buy" Rating Reaffirmed at HC Wainwright
4/1/2025 - MarketBeat
Wall Street Analysts Believe CG Oncology, Inc. (CGON) Could Rally 157.91%: Here's is How to Trade
3/31/2025 - Zacks Investment Research
CG Oncology Inc (CGON) Announces Key Presentations at AUA Annual Meeting 2025
3/31/2025 - GuruFocus
CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a ...
3/31/2025 - GuruFocus
CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates
3/31/2025 - Globe Newswire
Analysts Offer Insights on NA Companies: Nano Nuclear Energy Inc. (NNE) and CG Oncology, Inc. (CGON)
3/31/2025 - TipRanks Financial Blog
Company News for Mar 31, 2025
3/31/2025 - Zacks Investment Research
CG Oncology Full Year 2024 Earnings: Misses Expectations
3/29/2025 - Simply Wall St
Decoding CG Oncology Inc (CGON): A Strategic SWOT Insight
3/29/2025 - GuruFocus
CG Oncology Advances in Bladder Cancer Therapeutics
3/29/2025 - TipRanks Financial Blog
CG Oncology files automatic mixed securities shelf
3/28/2025 - TipRanks Financial Blog
CG Oncology files automatic mixed securities shelf
3/28/2025 - The Fly
CG Oncology Inc Reports Q4 2024 EPS of ($0.46), Missing Estimates, with Revenue at $1.14 Million
3/28/2025 - GuruFocus
CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates
3/28/2025 - GuruFocus
CG Oncology reports FY24 EPS ($1.41) vs ($15.65) last year
3/28/2025 - The Fly
CG Oncology Reports 2024 Year End Financial Results and Provides Business Updates
3/28/2025 - Globe Newswire
Swiss National Bank Has $2.28 Million Position in CG Oncology, Inc. (NASDAQ:CGON)
3/28/2025 - MarketBeat
Is CG Oncology (CGON) Among the Best IPO Stocks to Buy in 2025?
3/26/2025 - Insider Monkey
Income Statement
Total Revenue (TTM)
$1.14M
EBITDA (TTM)
-$114.63M
EBIT (TTM)
-$114.67M
Net Income (TTM)
-$88.04M
Balance Sheet
Total Assets (Q)
$754.80M
Total Debt (Q)
$238.00K
Total Liabilities (Q)
$21.42M
Book Value Per Share (Q)
$9.63
Cash Flow
Cash from Operations (TTM)
-$78.71M
Cash from Investing (TTM)
-$300.76M
Cash from Financing (TTM)
$628.28M
Net Change in Cash (TTM)
$248.80M
Filings
Filing Date
Friday, March 28, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
--
7-Day Total Return
-31.95%
30-Day Total Return
-33.59%
60-Day Total Return
-36.94%
90-Day Total Return
-41.87%
Year to Date Total Return
-35.31%
1-Year Total Return
-51.19%
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 02, 2025 - $21.61
52-week High
May 03, 2024 - $46.99
Valuation
Market Cap
$1.70B - Small Cap
Enterprise Value
$953.30M
Price/Sales (TTM)
1,356.10
Price/Book (Q)
2.31
Dividends and Shares
Shares Outstanding
69.05M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
cgoncology.com
Phone Number
949 409 3700
Address
400 Spectrum Center Drive
Irvine, CA 92618
Country
United States
Year Founded
2010
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
CG Oncology, Inc., a late-stage clinical biopharmaceutical company, focuses on developing and commercializing backbone bladder-sparing therapeutics for patients with bladder cancer. The company... more
NASDAQ 04/03/2025 4:00PM Eastern Quotes delayed
Weiss Ratings